Metabolic control of innate immune activation in TET2-mutant clonal hematopoiesis.

Kim, P. G., Hergott, C. B., Miller, A. P., Deik, A., Boileau, M., Bullock, K., Pierce, K. A., Choy, A. H., Shin, W., McConkey, M., Loke, J., Ryback, B. A., Trinh, M. N., Rutter, J. C., Yue, H., Yoon, H., Park, P., Burman, S. S. R., Heiden, M. G. V., … Ebert, B. L. (2026). Metabolic control of innate immune activation in TET2-mutant clonal hematopoiesis.. Cell Chemical Biology, 33(2), 183-197.e9.

Abstract

Somatic mutations in TET2 drive hyper-inflammation in clonal hematopoiesis of indeterminate potential (CHIP), but the molecular link between TET2 inactivation and myeloid immune activation remains unclear. We used in vivo genome-wide genetic perturbations enabled by ultra-diverse barcoding in primary wild-type (WT) or Tet2 knockout (KO) Cas9+ hematopoietic stem-progenitor cells (HSPCs) to elucidate the basis of Tet2 KO inflammation. We uncover a metabolic circuit by which Tet2 restrains O-linked N-acetylglucosamine (O-GlcNAc) glycosyltransferase (Ogt), a Tet2 binding partner and metabolic sensor. Tet2 loss disrupts this inhibitory Tet2-Ogt interaction, and dysregulated Ogt facilitates widespread H3K4 trimethylation including lipid-related gene loci and inflammatory lipid droplet formation. We identified that ATP citrate lyase (Acly) is decorated with O-GlcNAc and is a critical node for lipid accumulation and inflammation in Tet2 KO. These findings reveal that Tet2 suppresses inflammation by gating nutrient-responsive chromatin remodeling and nominate metabolic interventions to restrain inflammatory disease in TET2-mutant clonal hematopoiesis.

Last updated on 04/02/2026
PubMed